Diabetes

Parents ask Manitoba to offer insulin help for younger students in schools
Young children in some provinces get help from trained school personnel—often teaching assistants—in using their insulin pumps during the school day. But that's not the case in Manitoba.
A refresher on peripheral neuropathy
Comprehensive JAMA review highlights pathophysiology, clinical presentation, causes, diagnosis, management and prognosis.

SGLT2 inhibitors and infection risk in patients with type 2 diabetes

Systematic review and meta-analyses of real-world evidence examines the association of SGLT2 inhibitors and the risk of infections in patients with type 2 diabetes.
Environmental stewardship in diabetes care: actionable insights for pharmacists

As we enter Diabetes Month, this article looks at ways to foster preparedness and sustainable practices in the face of climate change.
Do GLP-1RAs alter the risk of developing age-related macular degeneration (AMD)?

Study compares the risk of developing nonexudative AMD and its progression to exudative AMD in patients with obesity taking GLP-1RAs vs other weight-loss drugs.
Obesity: Why do so many patients abandon GLP-1 agonists?

Despite the hype surrounding GLP-1 receptor agonists, a significant proportion of patients discontinue treatment after a few months, reducing the chances of long-term benefits.
GLP-1 inhibitors may protect against brain degeneration

Study participants who were treated with the GLP-1 inhibitor had a lower risk of dementia, ischemic stroke and all-cause mortality.
Let's get pumping!

Answers to common questions about insulin pump therapy.
Diabetes and visual impairment—you can help!

Any support you can provide to your sight-impaired patients can help keep them self-sufficient in their diabetes management.
Three new drugs pharmacists and physicians need to know about (plus three new generics)

Get the info you need on these new drugs, part of our drug news roundup for September.

Parents ask Manitoba to offer insulin help for younger students in schools

A refresher on peripheral neuropathy

SGLT2 inhibitors and infection risk in patients with type 2 diabetes

Environmental stewardship in diabetes care: actionable insights for pharmacists

Do GLP-1RAs alter the risk of developing age-related macular degeneration (AMD)?

Obesity: Why do so many patients abandon GLP-1 agonists?

GLP-1 inhibitors may protect against brain degeneration

Let's get pumping!

Diabetes and visual impairment—you can help!

Three new drugs pharmacists and physicians need to know about (plus three new generics)